HKD 7.71
(0.13%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -469.72 Million CNY | -20.8% |
2022 | -388.84 Million CNY | -70.9% |
2021 | -227.52 Million CNY | -488.08% |
2020 | -38.69 Million CNY | -129.49% |
2019 | 131.2 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -487.24 Million CNY | 4.05% |
2024 Q1 | -487.24 Million CNY | -3.73% |
2023 Q4 | -469.72 Million CNY | 2.21% |
2023 FY | -469.72 Million CNY | -20.8% |
2023 Q1 | -424.91 Million CNY | -9.28% |
2023 Q3 | -480.34 Million CNY | -14.36% |
2023 Q2 | -420.02 Million CNY | 1.15% |
2022 Q3 | -395.32 Million CNY | -10.09% |
2022 Q1 | -368.14 Million CNY | -61.8% |
2022 FY | -388.84 Million CNY | -70.9% |
2022 Q4 | -388.84 Million CNY | 1.64% |
2022 Q2 | -359.1 Million CNY | 2.45% |
2021 Q3 | -233.75 Million CNY | 0.0% |
2021 Q4 | -227.52 Million CNY | 2.66% |
2021 Q1 | 214.24 Million CNY | 0.0% |
2021 FY | -227.52 Million CNY | -488.08% |
2020 FY | -38.69 Million CNY | -129.49% |
2019 FY | 131.2 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Life Healthcare Group Limited | 5.23 Million HKD | 9074.532% |
China Biotech Services Holdings Limited | -106.5 Million HKD | -341.058% |